Sacyr S.A. buy krebskrebs
Start price
17.05.20
/
50%
€1.55
Target price
04.11.21
€1.92
Performance (%)
45.99%
End price
05.11.21
€2.27
Summary
This prediction ended on 05.11.21 with a price of €2.27. The BUY prediction by krebskrebs for Sacyr S.A. saw massive gains of 45.99%. Dividends of €0.066 are taken into consideration when calculating the performance. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Sacyr S.A. | 0.727% | 0.727% | 11.461% | 54.554% |
iShares Core DAX® | 2.594% | -1.158% | 14.782% | 16.813% |
iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% | 44.227% |
iShares Nikkei 225® | 0.687% | -8.354% | 18.454% | 1.361% |
iShares S&P 500 | 2.209% | -0.942% | 31.361% | 42.812% |
Comments by krebskrebs for this prediction
In the thread Sacyr S.A. diskutieren
Buy mit Kursziel 2,0
In the thread Trading Sacyr S.A.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten